These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17393321)

  • 1. Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.
    Theocharis S; Giaginis C; Parasi A; Margeli A; Kakisis J; Agapitos E; Kouraklis G
    Dig Dis Sci; 2007 Sep; 52(9):2305-11. PubMed ID: 17393321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor (GR) immunohistochemical expression is correlated with cell cycle-related molecules in human colon cancer.
    Theocharis S; Kouraklis G; Margeli A; Agapitos E; Ninos S; Karatzas G; Koutselinis A
    Dig Dis Sci; 2003 Sep; 48(9):1745-50. PubMed ID: 14560994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.
    Giaginis C; Politi E; Alexandrou P; Sfiniadakis J; Kouraklis G; Theocharis S
    Pathol Oncol Res; 2012 Oct; 18(4):875-83. PubMed ID: 22426809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of G1 Cyclins, p21 and Rb Protein in Patients With Colon Cancer.
    Palaiologos P; Chrysikos D; Theocharis S; Kouraklis G
    Anticancer Res; 2019 Nov; 39(11):6291-6297. PubMed ID: 31704859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.
    Yoshizumi T; Ohta T; Ninomiya I; Terada I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Yi S; Miwa K
    Int J Oncol; 2004 Sep; 25(3):631-9. PubMed ID: 15289864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade.
    Theocharis S; Kanelli H; Politi E; Margeli A; Karkandaris C; Philippides T; Koutselinis A
    Lung Cancer; 2002 Jun; 36(3):249-55. PubMed ID: 12009233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression.
    Konstantinopoulos PA; Vandoros GP; Sotiropoulou-Bonikou G; Kominea A; Papavassiliou AG
    Int J Colorectal Dis; 2007 Jan; 22(1):57-68. PubMed ID: 16506021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
    J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
    Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
    Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Satre-Garau X
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):251-9. PubMed ID: 20390425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
    Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
    Takano S; Kubota T; Nishibori H; Hasegawa H; Ishii Y; Nitori N; Ochiai H; Okabayashi K; Kitagawa Y; Watanabe M; Kitajima M
    Anticancer Res; 2008; 28(6A):3593-9. PubMed ID: 19189639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.